Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Список исп. литературыСкрыть список 1. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med 2005; 67: 89–97. 2. Denollet J, Schiffer AA, Spek V. A general propensity to psychological distress affects cardiovascular outcomes: evidence from research on the Type D (distressed) personality profile. Circ Cardiovasc Qual Outcomes 2010; 3: 546–57. 3. Denollet J, Sys SU, Stroobant N et al. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996; 347: 417–21. 4. Hausteiner C, Klupsch D, Emeny R et al. Clustering of negative affectivity and social inhibition in the community: prevalence of type D personality as a cardiovascular risk marker. Psychosom Med 2010; 2: 163–71. 5. Grande G, Jordan J, Kmmel M et al. Evaluation der deutschen Typ D-Skala (DS14) und Prevalenz der Typ D-Personlichkeit bei cardiologischen und psychosomatischen Patienten sowie Gesunden. Psychother Psychosom Med Psychol 2004; 54: 413–22. 6. Martens EJ, Kupper N, Pedersen SS et al. Type-D personality is a stable taxonomy in post-MI patients over an 18-month period. J Psychosom Res 2007; 63: 545–50. 7. Pelle AJ, Erdman RA, van Domburg RT et al. Type D patients report poorer health status prior to and after cardiac rehabilitation compared to non-type D patients. Ann Behav Med 2008; 36: 167–75. 8. Kupper N, Boomsma DI, de Geus EJ et al. Nine-year stability of Type D personality: contributions of genes and environment. Psychosom Med 2011; 73: 75–82. 9. Dannemann S, Matschke K, Einsle F et al. Is type-D a stable construct? An examination of type-D personality in patients before and after cardiac surgery. J Psychosom Res 2010; 69: 101–9. 10. Denollet J, Vaes J, Brutsaert DL. Inadequate response to treatment in coronary heart disease: adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation 2000; 102: 630–5. 11. Martens EJ, Mols F, Burg MM, Denollet J. Type D personality predicts clinical events after myocardial infarction, above and beyond disease severity and depression. J Clin Psychiat 2010; 71: 778–83. 12. Reich J, Schatzberg A. Personality traits and medical outcome of cardiac illness. J Psychiat Res 2010; 44: 1017–20. 13. Schiffer AA, Pedersen SS, Widdershoven JW, Denollet J. Type D personality and depressive symptoms are independent predictors of impaired health status in chronic heart failure. Eur J Heart Fail 2008; 10: 922–30. 14. Schiffer AA, Pedersen SS, Broers H et al. Type-D personality but not depression predicts severity of anxiety in heart failure patients at 1-year follow-up. J Affect Dis 2008; 106: 73–81. 15. Schiffer AA, Smith OR, Pedersen SS et al. Type D personality and cardiac mortality in patients with chronic heart failure. Int J Cardiol 2010; 142: 230–5. 16. Schiffer AA, Pedersen SS, Widdershoven JW et al. The distressed (Type D) personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005; 12: 341–6. 17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiat Scand 1983; 67: 361–70. 18. Lowe B, Spitzer RL, Grafe K et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Dis 2004; 78: 131–40. 19. Michal M, Wiltink J, Till Y et al. Type-D personality and depersonalization are associated with suicidal ideation in the German general population aged 35–74: results from the Gutenberg Heart Study. J Affect Dis 2010; 125: 227–33. 20. Martens EJ, Smith OR, Winter J et al. Cardiac history, prior depression and personality predict course of depressive symptoms after myocardial infarction. Psychol Med 2008; 38: 257–64. 21. Pedersen SS, van Domburg RT, Theuns DA et al. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med 2004; 66: 714–9. 22. Pelle AJ, Denollet J, Zwisler AD, Pedersen SS. Overlap and distinctiveness of psychological risk factors in patients with ischemic heart disease and chronic heart failure: are we there yet? J Affect Dis 2009; 113: 150–6. 23. Spindler H, Kruse C, Zwisler AD, Pedersen SS. Increased anxiety and depression in Danish cardiac patients with a type D personality: cross-validation of the Type D Scale (DS14). Int J Behav Med 2009; 16: 98–107. 24. Schiffer AA, Denollet J, Widdershoven JW et al. Failure to consult for symptoms of heart failure in patients with a type-D personality. Heart 2007; 93: 814–8. 25. Pelle AJ, Schiffer AA, Smith OR et al. Inadequate consultation behavior modulates the relationship between type D personality and impaired health status in chronic heart failure. Int J Cardiol 2010; 142: 65–71. 26. Whitehead DL, Perkins-Porras L, Strike PC et al. Cortisol awakening response is elevated in acute coronary syndrome patients with type-D personality. J Psychosom Res 2007; 62: 419–25. 27. Molloy GJ, Perkins-Porras L, Strike PC, Steptoe A. Type-D personality and cortisol in survivors of acute coronary syndrome. Psychosom Med 2008; 70: 863–8. 28. Kupper N, Gidron Y, Winter J, Denollet J. Association between type D personality, depression, and oxidative stress in patients with chronic heart failure. Psychosom Med 2009; 71: 973–80. 29. Denollet J, Schiffer AA, Kwaijtaal M et al. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure. Am J Cardiol 2009; 103: 399–404. 30. Skapinakis P. The 2-item Generalized Anxiety Disorder scale had high sensitivity and specificity for detecting GAD in primary care. Evid Based Med 2007; 12: 149. 31. Connor KM, Kobak KA, Churchill LE et al. Mini-SPIN: a brief screening assessment for generalized social anxiety disorder. Depress Anxiety 2001; 14: 137–40. 32. Lowe B, Grfe K, Zipfel S et al. Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the hospital anxiety and depression scale, the patient health questionnaire, a screening question, and physicians’ diagnosis. J Psychosom Res 2003; 55: 515–9. 33. Michal M, Zwerenz R, Tschan R et al. Screening for depersonalization-derealization with two items of the Cambridge Depersonalization Scale. Psychother Psychosom Med Psychol 2010; 60: 175–9. 34. Michal M, Wiltink J, Subic-Wrana C et al. Prevalence, correlates, and predictors of depersonalization experiences in the German general population. J Nerv Ment Dis 2009; 197: 499–506. 35. Kelly DH, Walter CJ. The relationship between clinical diagnosis and anxiety, assessed by forearm blood flow and other measurements. Br J Psychiat 1968; 114: 611–26. 36. Wendel-Vos GC, Schuit AJ, Saris WH et al. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 2003; 56: 1163–9. 37. Ainsworth BE, Haskell WL, Leon AS et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25: 71–80. 38. Lampert T, Kroll LE. Die Messung des so ziokonomischen Status in sozialepidemiologischen Studien. In: M.Richter, K.Hurrelmann (eds): Gesundheitliche Ungleichheit. Wiesbaden, VS Verlag fr Sozialwissenschaften 2009; pp. 309–34. 39. Broek KC, Smolderen KG, Pedersen SS, Denollet J. Type D personality mediates the relationship between remembered parenting and perceived health. Psychosomatics 2010; 51: 216–24. 40. Mols F, Denollet J. Type D personality among noncardiovascular patient populations: a systematic review. Gen Hosp Psychiat 2010; 32: 66–72. 41. Mols F, Denollet J. Type D personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems. Health Qual Life Outcomes 2010; 8: 9. 42. Yu DS, Thompson DR, Yu CM et al. Validating the type D personality construct in Chinese patients with coronary heart disease. J Psychosom Res 2010; 69: 111–8. 43. Pietrzak RH, Wagner JA, Petry NM. DSMIV personality disorders and coronary heart disease in older adults: results from the national epidemiologic survey on alcohol and related conditions. J Gerontol B Psychol Sci Soc Sci 2007; 62: 295–9. 44. Michal M, Wiltink J, Till Y et al. Distinctiveness and overlap of depersonalization with anxiety and depression in a community sample: results from the Gutenberg Heart Study. Psychiat Res 2011; 188: 264–8. 45. Pizzi C, Manzoli L, Mancini S, Costa GM. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J 2008; 29: 1110–7. 46. Ali S, Garg SK, Cohen BE et al. Association between omega-3 fatty acids and depressive symptoms among patients with established coronary artery disease: data from the heart and soul study. Psychother Psychosom 2009; 78: 125–7. 47. Rapp MA, Rieckmann N, Lessman DA et al. Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: a pilot study. Psychother Psychosom 2010; 79: 149–55. 48. Yoon SJ, Kim TS, Seung KB et al. Role of depressive symptoms in coronary artery spasm. Psychother Psychosom 2009; 79: 191–3. 49. Bui E, Cailhol L, Puel J et al. Effects of depressive symptoms, anxiety and alexithymia on physical functioning 6 months after percutaneous transluminal coronary angioplasty. Psychother Psychosom 2009; 79: 59–60. 50. Zuidersma M, Thombs BD, de Jonge P. Onset and recurrence of depression as predictors of cardiovascular prognosis in depressed acute coronary syndrome patients: a systematic review. Psychother Psychosom 2011; 80: 227–37. 51. Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between major depressive disorder and C-reactive protein levels in stable coronary heart disease patients. J Psychosom Res 2009; 66: 189–94. 52. Konel RV, Bellingrath S, Kudielka BM. Association between longitudinal changes in depressive symptoms and plasma fibrinogen levels in school teachers. Psychophysiol 2009; 46: 473–80. 53. Panagiotakos DB, Pitsavos C, Chrysohoou C et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the Attica Study. Eur Heart J 2004; 25: 492–9. 54. Politi P, Minoretti P, Piaggi N et al. Elevated plasma N-terminal Pro BNP levels in unmedicated patients with major depressive disorder. Neurosci Lett 2007; 417: 322–5.